Enhanced liver fibrosis score predicts transplant-free survival in primary sclerosing cholangitis
Open accessAbstract
There is a need to determine biomarkers reflecting disease activity and prognosis in primary sclerosing cholangitis (PSC). We evaluated the prognostic utility of the enhanced liver fibrosis (ELF) score in Norwegian PSC patients. Serum samples were available from 305 well‐characterized large‐duct PSC patients, 96 ulcerative colitis patients, and 100 healthy controls. The PSC patients constituted a derivation panel (recruited 1992‐2006 [n = 167]; median age 41 years, 74% male) and a validation panel (recruited 2008‐2012 [n = 138]; median age 40 years, 78% male). We used commercial kits to analyze serum levels of hyaluronic acid, tissue inhibitor of metalloproteinases‐1, and propeptide of type III procollagen and calculated ELF scores by the previously published algorithm. Results were also validated by analysis of ELF tests using the ADVIA Centaur XP system and its commercially available reagents. We found that PSC patients stratified by ELF score tertiles exhibited significantly different transplant‐free survival in both panels ( P < 0.001), with higher scores associated with shorter survival, which was confirmed in the validation panel stratified by ELF test tertiles ( P = 0.003). The ELF test distinguished between mild and severe disease defined by clinical outcome (transplantation or death) with an area under the curve of 0.81 (95% confidence interval [CI] 0.73‐0.87) and optimal cutoff of 10.6 (sensitivity 70.2%, specificity 79.1%). In multivariate Cox regression analysis in both panels, ELF score (hazard ratio = 1.9, 95% CI 1.4‐2.5, and 1.5, 95% CI 1.1‐2.1, respectively) was associated with transplant‐free survival independently of the Mayo risk score (hazard ratio = 1.3, 95% CI 1.1‐1.6, and 1.6, 95% CI 1.2‐2.1, respectively). The ELF test correlated with ultrasound elastography in separate assessments. Conclusion : The ELF score is a potent prognostic marker in PSC, independent of the Mayo risk score. (H epatology 2015;62:188‐197)
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The ELF test can predict transplant-free survival in PSC and retains predictive value longitudinally despite dynamic fluctuations in the course of PSC with regard to progression to cirrhosis, but without association between reduced values and improved outcome.
“The ELF test can predict transplant-free survival in PSC 81,82 and retains predictive value longitudinally despite dynamic fluctuations in the course of PSC with regard to progression to cirrhosis (but without association between reduced values and improved outcome).79”
From EASL Clinical Practice Guidelines on sclerosing cholangitis (2022) · cites this paper as [81]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
DeLong, E. R., DeLong, D. M., & Clarke-Pearson, D. L. (1988) · Biometrics · doi:10.2307/2531595 · Cited by 22,649 · see citing works
Proportional hazards tests and diagnostics based on weighted residuals
GRAMBSCH, P. M., & THERNEAU, T. M. (1994) · Biometrika · doi:10.1093/biomet/81.3.515 · Cited by 5,885 · see citing works
Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers
Pencina, M. J., D’Agostino, R. B., & Steyerberg, E. W. (2010) · Statistics in Medicine · doi:10.1002/sim.4085 · Cited by 2,478 · see citing works
Sampling Variability of Liver Fibrosis in Chronic Hepatitis C
Bédossa, P., Dargère, D., & Paradis, V. (2003) · Hepatology · doi:10.1016/j.hep.2003.09.022 · Cited by 2,370 · see citing works
EASL Clinical Practice Guidelines: management of cholestatic liver diseases
European Association for the Study of the Liver (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.04.009 · Cited by 1,729 · see citing works
Diagnosis and Management of Primary Sclerosing Cholangitis
Chapman, R. W., Fevery, J., Kalloo, A. N., Nagorney, D. M., Boberg, K. M., Shneider, B. L., & Gores, G. J. (2009) · Hepatology · doi:10.1002/hep.23294 · Cited by 1,217 · see citing works
Self-citationSerum markers detect the presence of liver fibrosis: A cohort study
Rosenberg, W. M., Voelker, M., Thiel, R. P., Becka, M., Burt, A. D., Schuppan, D., Hübscher, S. G., Roskams, T., Pinzani, M., & Arthur, M. J. P. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.08.052 · Cited by 1,103 · see citing works
Self-citationNatural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis.
Broomé, U., Olsson, R., Lööf, L., Bodemar, G., Hultcrantz, R., Danielsson, A., Prytz, H., Sandberg–Gertzén, H., Wallerstedt, S. M., & Lindberg, G. (1996) · Gut · doi:10.1136/gut.38.4.610 · Cited by 816 · see citing works
Guha, I. N., Parkes, J., Roderick, P. J., Chattopadhyay, D., Cross, R., Harris, S., Kaye, P., Burt, A. D., Ryder, S. D., Aithal, G. P., et al. (2007) · Hepatology · doi:10.1002/hep.21984 · Cited by 744 · see citing works
Self-citationSolberg, I. C., Lygren, I., Jahnsen, J., Aadland, E., Høie, O., Cvancarova, M., Bernklev, T., Henriksen, M., Sauar, J., Vatn, M. H., et al. (2008) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520802600961 · Cited by 729 · see citing works
Self-citationBoonstra, K., Weersma, R. K., van Erpecum, K. J., Rauws, E. A., Spanier, B. W. M., Poen, A. C., van Nieuwkerk, K. M., Drenth, J. P., Witteman, B. J., Tuynman, H. A., et al. (2013) · Hepatology · doi:10.1002/hep.26565 · Cited by 725 · see citing works
Self-citationMaharaj, B., Leary, W. P., Naran, A. D., Maharaj, R., Cooppan, R. M., Pirie, D. J., & Pudifin, D. J. (1986) · The Lancet · doi:10.1016/s0140-6736(86)90883-4 · Cited by 606 · see citing works
Primary sclerosing cholangitis
Hirschfield, G. M., Karlsen, T. H., Lindor, K. D., & Adams, D. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60096-3 · Cited by 599 · see citing works
Self-citationNatural history and prognostic variables in primary sclerosing cholangitis
Farrant, J. M., Hayllar, K. M., Wilkinson, M. L., Karani, J., Portmann, B. C., Westaby, D., & Williams, R. (1991) · Gastroenterology · doi:10.1016/0016-5085(91)90673-9 · Cited by 468 · see citing works
A Revised Natural History Model for Primary Sclerosing Cholangitis
Kim, W. R., Therneau, T. M., Wiesner, R. H., Poterucha, J. J., Benson, J. T., Malinchoc, M., LaRusso, N. F., Lindor, K. D., & Dickson, E. R. (2000) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(11)64614-4 · Cited by 434 · see citing works
Tischendorf, J. J. W., Hecker, H., Krüger, M., Manns, M. P., & Meier, P. N. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00872.x · Cited by 413 · see citing works
Enhanced liver fibrosis test can predict clinical outcomes in patients with chronic liver disease
Parkes, J., Roderick, P. J., Harris, S., Day, C. P., Mutimer, D., Collier, J. D., Lombard, M., Alexander, G., Ramage, J. K., Dusheiko, G. M., et al. (2010) · Gut · doi:10.1136/gut.2009.203166 · Cited by 349 · see citing works
Self-citationCholangiocarcinoma in Primary Sclerosing Cholangitis: Risk Factors and Clinical Presentation
Boberg, K. M., Bergquist, A. M., Mitchell, S. A., Parés, A. R., Rosina, F., Broomé, U., Chapman, R. W., FAUSA, O., EGELAND, T., Rocca, G., et al. (2002) · Scandinavian Journal of Gastroenterology · doi:10.1080/003655202760373434 · Cited by 309 · see citing works
Self-citationCorpechot, C., Gaouar, F., El Naggar, A., Kemgang, A., Wendum, D., Poupon, R., Carrat, F., & Chazouillères, O. (2014) · Gastroenterology · doi:10.1053/j.gastro.2013.12.030 · Cited by 300 · see citing works
Ponsioen, C. Y., Vrouenraets, S. M. E., Prawirodirdjo, W., Rajaram, R., Rauws, E. A., Mulder, C. J. J., Reitsma, J. B., Heisterkamp, S. H., & Tytgat, G. N. J. (2002) · Gut · doi:10.1136/gut.51.4.562 · Cited by 267 · see citing works
Self-citationPrimary sclerosing cholangitis: refinement and validation of survival models.
Dickson, E., Murtaugh, P., Wiesner, R., Grambsch, P. M., Fleming, T. R., Ludwig, J., LaRusso, N., Malinchoc, M., Chapman, R., Kaplan, M., et al. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)91449-e · Cited by 265 · see citing works
High-dose ursodeoxycholic acid as a therapy for patients with primary sclerosing cholangitis
Harnois, D. M., Angulo, P., Jorgensen, R. A., LaRusso, N. F., & Lindor, K. D. (2001) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2001.03777.x · Cited by 242 · see citing works
Mamari, S. A., Djordjevic, J., Halliday, J., & Chapman, R. W. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.10.013 · Cited by 202 · see citing works
Prediction of clinical outcomes in primary biliary cirrhosis by serum enhanced liver fibrosis assay
Mayo, M. J., Parkes, J., Adams-Huet, B., Combes, B., Mills, A. S., Markin, R. S., Rubin, R., Wheeler, D., Contos, M., West, A. B., et al. (2008) · Hepatology · doi:10.1002/hep.22517 · Cited by 198 · see citing works
Self-citationLindström, L., Hultcrantz, R. W., Boberg, K. M., Friis–Liby, I., & Bergquist, A. M. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.12.032 · Cited by 178 · see citing works
Self-citationClinicopathologic Study of Cholangiocarcinoma With Superficial Spread
Igami, T., Nagino, M., Oda, K., Nishio, H., Ebata, T., Yokoyama, Y., & Shimoyama, Y. (2009) · Annals of Surgery · doi:10.1097/sla.0b013e318190a647 · Cited by 167 · see citing works
Crespo, G., Fernández‐Varo, G., Mariñó, Z., Casals, G., Miquel, R., Martínez, S. M., Gilabert, R., Forns, X., Jiménez, W., & Navasa, M. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.03.016 · Cited by 163 · see citing works
Stanich, P. P., Björnsson, E., Gossard, A. A., Enders, F., Jorgensen, R. A., & Lindor, K. D. (2011) · Digestive and Liver Disease · doi:10.1016/j.dld.2010.12.008 · Cited by 160 · see citing works
Kim, W. R., Poterucha, J. J., Wiesner, R. H., LaRusso, N. F., Lindor, K. D., Petz, J., Therneau, T. M., Malinchoc, M., & Dickson, R. E. (1999) · Hepatology · doi:10.1002/hep.510290607 · Cited by 137 · see citing works
Primary Sclerosing Cholangitis and Cholangiocarcinoma
Lazaridis, K. N., & Gores, G. J. (2006) · Seminars in Liver Disease · doi:10.1055/s-2006-933562 · Cited by 136 · see citing works
Cullen, S. N., Rust, C., Fleming, K., Edwards, C., Beuers, U., & Chapman, R. W. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2007.12.023 · Cited by 136 · see citing works
Surgical pathology of the syndrome of primary sclerosing cholangitis.
Ludwig, J. (1989) · PubMed · Cited by 113 · see citing works
The Significance of Stromal Desmoplasia in Intrahepatic Cholangiocarcinoma
Kajiyama, K., Maeda, T., Takenaka, K., Sugimachi, K., & Tsuneyoshi, M. (1999) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199908000-00006 · Cited by 110 · see citing works
Martinez, S. M., Fernández‐Varo, G., González, P., Sampson, E., Bruguera, M., Navasa, M., Jiménez, W., Sánchez-Tapias, J. M., & Forns, X. (2010) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2010.04500.x · Cited by 106 · see citing works
Accuracy of staging in primary biliary cirrhosis.
Garrido, M. C., & Hübscher, S. G. (1996) · Journal of Clinical Pathology · doi:10.1136/jcp.49.7.556 · Cited by 92 · see citing works
Boberg, K. M., Rocca, G., Egeland, T., Bergquist, A. M., Broomé, U., Caballería, L., Chapman, R. W., Hultcrantz, R. W., Mitchell, S., Parés, A. R., et al. (2002) · Hepatology · doi:10.1053/jhep.2002.31872 · Cited by 92 · see citing works
Self-citationKarlsen, T. H., Vesterhus, M. N., & Boberg, K. M. (2013) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12581 · Cited by 86 · see citing works
Self-citationIntrahepatic cholangiectases and large-duct obliteration in primary sclerosing cholangitis
Ludwig, J., MacCarty, R. L., LaRusso, N. F., Krom, R. A. F., & Wiesner, R. H. (1986) · Hepatology · doi:10.1002/hep.1840060403 · Cited by 83 · see citing works
Wiesner, R. H. (2001) · Best Practice & Research Clinical Gastroenterology · doi:10.1053/bega.2001.0212 · Cited by 68 · see citing works
Trépo, E., Potthoff, A., Pradat, P., Bakshi, R. K., Young, B. A., LAGIER, R. J., Moreno, C., Verset, L., Cross, R., Degré, D., et al. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.10.018 · Cited by 57 · see citing works
Self-citationPetrovic, B. D., Nikolaidis, P., Hammond, N. A., Martin, J. A., Petrovic, P. V., Desai, P., & Miller, F. H. (2007) · Digestive Diseases and Sciences · doi:10.1007/s10620-006-9720-1 · Cited by 40 · see citing works
Flagged first, then by citations
Research works printed but not linked: 1
- Hirschfield GM, Karlsen TH, Lindor KD, Adams DH. Primary scle- rosing cholangitis. Lancet 2013;382:1587-1599.
Cited by
Sorted by citations
Berzigotti, A., Tsochatzis, E., Boursier, J., Castera, L., Cazzagon, N., Friedrich-Rust, M., Petta, S., & Thiele, M. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.05.025 · Cited by 1,925 · see citing works
Primary sclerosing cholangitis – a comprehensive review
Karlsen, T. H., Folseraas, T., Thorburn, D., & Vesterhus, M. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.07.022 · Cited by 868 · see citing works
Self-citationVilar‐Gómez, E., & Chalasani, N. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.11.013 · Cited by 608 · see citing works
Weismüller, T. J., Trivedi, P. J., Bergquist, A., Imam, M., Lenzen, H., Ponsioen, C. Y., Holm, K., Gotthardt, D., Färkkilä, M. A., Marschall, H.-U., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.02.038 · Cited by 533 · see citing works
Self-citationPrimary sclerosing cholangitis
Dyson, J. K., Beuers, U. H., Jones, D. E. J., Lohse, A. W., & Hudson, M. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30300-3 · Cited by 479 · see citing works
AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma
Bowlus, C. L., Arrivé, L., Bergquist, A. M., Deneau, M. R., Forman, L., Ilyas, S. I., Lunsford, K. E., Martínez, M., Sapisochín, G., Shroff, R. T., et al. (2022) · Hepatology · doi:10.1002/hep.32771 · Cited by 448 · see citing works
EASL Clinical Practice Guidelines on sclerosing cholangitis
Chazouilleres, O., Beuers, U., Bergquist, A., Karlsen, T. H., Levy, C., Samyn, M., Schramm, C., & Trauner, M. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.05.011 · Cited by 419 · see citing works
Self-citationnorUrsodeoxycholic acid improves cholestasis in primary sclerosing cholangitis
Fickert, P., Hirschfield, G. M., Denk, G., Marschall, H.-U., Altorjay, I., Färkkilä, M., Schramm, C., Spengler, U., Chapman, R., Bergquist, A., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.05.009 · Cited by 297 · see citing works
Self-citationChapman, M. H., Thorburn, D., Hirschfield, G. M., Webster, G. G. J., Rushbrook, S. M., Alexander, G., Collier, J., Dyson, J. K., Jones, D. E., Patanwala, I., et al. (2019) · Gut · doi:10.1136/gutjnl-2018-317993 · Cited by 284 · see citing works
Self-citationTrauner, M. A., Gulamhusein, A. F., Hameed, B., Caldwell, S. H., Shiffman, M. L., Landis, C. S., Eksteen, B., Agarwal, K., Muir, A. J., Rushbrook, S., et al. (2019) · Hepatology · doi:10.1002/hep.30509 · Cited by 263 · see citing works
Deneau, M. R., El‐Matary, W., Valentino, P. L., Abdou, R., Alqoaer, K., Amin, M., Amir, A. Z., Auth, M., Bazerbachi, F., Broderick, A., et al. (2017) · Hepatology · doi:10.1002/hep.29204 · Cited by 230 · see citing works
Hirschfield, G. M., Chazouillères, O., Drenth, J. P., Thorburn, D., Harrison, S. A., Landis, C. S., Mayo, M. J., Muir, A. J., Trotter, J. F., Leeming, D. J., et al. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2018.10.035 · Cited by 187 · see citing works
Self-citationPonsioen, C. Y., Chapman, R. W., Chazouillères, O., Hirschfield, G. M., Karlsen, T. H., Lohse, A. W., Pinzani, M., Schrumpf, E., Trauner, M. A., & Gores, G. J. (2015) · Hepatology · doi:10.1002/hep.28256 · Cited by 177 · see citing works
Self-citationEaton, J. E., Vesterhus, M. N., McCauley, B. M., Atkinson, E. J., Schlicht, E. M., Juran, B. D., Gossard, A. A., LaRusso, N. F., Gores, G. J., Karlsen, T. H., et al. (2018) · Hepatology · doi:10.1002/hep.30085 · Cited by 154 · see citing works
Self-citationAltered gut microbial metabolism of essential nutrients in primary sclerosing cholangitis
Kummen, M., Thingholm, L. B., Rühlemann, M. C., Holm, K., Hansen, S. H., Moitinho-Silva, L., Liwinski, T., Zenouzi, R., Storm-Larsen, C., Midttun, Ø., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2020.12.058 · Cited by 129 · see citing works
Self-citationGoode, E. C., Clark, A., Mells, G. F., Srivastava, B., Spiess, K., Gelson, W., Trivedi, P. J., Lynch, K. D., Castren, E., Vesterhus, M. N., et al. (2018) · Hepatology · doi:10.1002/hep.30479 · Cited by 106 · see citing works
Self-citationde Vries, E. M. G., de Krijger, M., Färkkilä, M. A., Arola, J. T., Schirmacher, P., Gotthardt, D. N., Goeppert, B. F., Trivedi, P. J., Hirschfield, G. M., Ytting, H., et al. (2016) · Hepatology · doi:10.1002/hep.28963 · Cited by 105 · see citing works
Self-citationMousa, O. Y. S., Juran, B. D., McCauley, B. M., Vesterhus, M. N., Folseraas, T., Turgeon, C. T., Ali, A. H., Schlicht, E. M., Atkinson, E. J., Hu, C., et al. (2020) · Hepatology · doi:10.1002/hep.31652 · Cited by 102 · see citing works
Self-citationPonsioen, C. Y., Assis, D. N., Boberg, K. M., Bowlus, C. L., Deneau, M., Thorburn, D., Aabakken, L., Färkkilä, M., Petersen, B., Rupp, C., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.07.046 · Cited by 95 · see citing works
Self-citationHyaluronan in immune dysregulation and autoimmune diseases
Nagy, N., Kuipers, H. F., Marshall, P. L., Wang, E., Kaber, G., & Bollyky, P. L. (2018) · Matrix Biology · doi:10.1016/j.matbio.2018.03.022 · Cited by 91 · see citing works
de Vries, E. M. G., Färkkilä, M., Milkiewicz, P., Hov, J. R., Eksteen, B., Thorburn, D., Chazouillères, O., Pares, A., Nygård, S., Gilja, O. H., et al. (2017) · Liver International · doi:10.1111/liv.13402 · Cited by 83 · see citing works
Self-citationTrivedi, P. J., Tickle, J., Vesterhus, M. N., Eddowes, P. J., Bruns, T., Vainio, J., Parker, R., Smith, D., Liaskou, E., Thorbjørnsen, L. W., et al. (2017) · Gut · doi:10.1136/gutjnl-2016-312354 · Cited by 83 · see citing works
Self-citationS2k Leitlinie Autoimmune Lebererkrankungen
Authors, Collaborators:, durch:, E. B., Deutsche Gesellschaft für Gastroenterologie, V. U. S. (. (., (DGIM), D. G. F. I. M., (DCCV), D. M. C. U. V., e.V., D. L., (DEGUM), D. G. F. U. I. D. M., (DGE-BV), D. G. F. E. U. B. V., (DGKJ), D. G. F. K. U. J., et al. (2017) · Zeitschrift für Gastroenterologie · doi:10.1055/s-0043-120199 · Cited by 85 · see citing works
Vesterhus, M. N., & Karlsen, T. H. (2020) · Journal of Gastroenterology · doi:10.1007/s00535-020-01681-z · Cited by 80 · see citing works
Self-citationNordenvall, C., Olén, O., Nilsson, P. J., von Seth, E., Ekbom, A., Bottai, M., Myrelid, P., & Bergquist, A. (2018) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14393 · Cited by 78 · see citing works
Vesterhus, M. N., Holm, A., Hov, J. R., Nygård, S., Schrumpf, E., Melum, E., Thorbjørnsen, L. W., Paulsen, V., Lundin, K. E. A., Dale, I., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.01.019 · Cited by 75 · see citing works
Self-citationDesign and Endpoints for Clinical Trials in Primary Sclerosing Cholangitis
Ponsioen, C. Y., Lindor, K. D., Mehta, R., & Dimick‐Santos, L. (2018) · Hepatology · doi:10.1002/hep.29882 · Cited by 73 · see citing works
Self-citationDay, J. W., Patel, P. J., Parkes, J., & Rosenberg, W. M. (2018) · The Journal of Applied Laboratory Medicine · doi:10.1373/jalm.2018.027359 · Cited by 73 · see citing works
Self-citationTrivedi, P. J., Corpechot, C., Pares, A., & Hirschfield, G. M. (2016) · Hepatology · doi:10.1002/hep.28128 · Cited by 71 · see citing works
Self-citationGallbladder and bile duct disease in Cystic Fibrosis
Assis, D. N., & Debray, D. (2017) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2017.07.006 · Cited by 71 · see citing works
Ehlken, H., Wroblewski, R., Corpechot, C., Arrivé, L., Rieger, T., Hartl, J., Lezius, S., Huebener, P., Schulze, K., Zenouzi, R., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0164224 · Cited by 69 · see citing works
Giuffrida, P., Pinzani, M., Corazza, G. R., & Sabatino, A. D. (2016) · United European Gastroenterology Journal · doi:10.1177/2050640616640160 · Cited by 64 · see citing works
Self-citationPrimary sclerosing cholangitis
Rabiee, A., & Silveira, M. G. (2020) · Translational Gastroenterology and Hepatology · doi:10.21037/tgh-20-266 · Cited by 65 · see citing works
Kim, M. N., Han, J. W., An, J., Kim, B. K., Jin, Y., Kim, S., Lee, M., Lee, H. A., Cho, Y., Kim, H. Y., et al. (2024) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2024.0506 · Cited by 62 · see citing works
Primary sclerosing cholangitis
Manns, M. P., Bergquist, A. M., Karlsen, T. H., Levy, C., Muir, A. J., Ponsioen, C. Y., Trauner, M., Wong, G. L., & Younossi, Z. M. (2025) · Nature Reviews Disease Primers · doi:10.1038/s41572-025-00600-x · Cited by 71 · see citing works
Self-citationAn, P., Wei, G., Huang, P., Li, W., Qi, X., Lin, Y., Vaid, K. A., Wang, J., Zhang, S., Li, Y., et al. (2020) · Liver International · doi:10.1111/liv.14490 · Cited by 57 · see citing works
Asrani, S. K. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2015.07.030 · Cited by 56 · see citing works
Trivedi, P. J., Muir, A. J., Levy, C., Bowlus, C. L., Manns, M. P., Lu, X., Crans, G., Chung, C., Subramanian, G. M., Myers, R. P., et al. (2021) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2020.07.032 · Cited by 55 · see citing works
Recent Advances in the Management of Primary Sclerosing Cholangitis
Assis, D. N., & Bowlus, C. L. (2023) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2023.04.004 · Cited by 55 · see citing works
Tabibian, J. H., Ali, A. H., & Lindor, K. D. (2018) · Europe PMC (PubMed Central) · Cited by 55 · see citing works
Efficacy and Safety of Cenicriviroc in Patients With Primary Sclerosing Cholangitis: PERSEUS Study
Eksteen, B., Bowlus, C. L., Montaño‐Loza, A. J., Lefebvre, E. A., Fischer, L., Vig, P., Martins, E. B., Ahmad, J., Yimam, K. K., Pockros, P. J., et al. (2020) · Hepatology Communications · doi:10.1002/hep4.1619 · Cited by 51 · see citing works
New Therapeutic Strategies for Primary Sclerosing Cholangitis
Williamson, K. D., & Chapman, R. W. (2016) · Seminars in Liver Disease · doi:10.1055/s-0035-1571274 · Cited by 46 · see citing works
Goet, J. C., Floreani, A., Verhelst, X., Cazzagon, N., Perini, L., Lammers, W. J., de Vries, A. C., van der Meer, A. J., van Buuren, H. R., & Hansen, B. E. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.06.012 · Cited by 46 · see citing works
Trauner, M. A., Bowlus, C. L., Gulamhusein, A. F., Hameed, B., Caldwell, S. H., Shiffman, M. L., Landis, C. S., Muir, A. J., Billin, A. N., Xu, J., et al. (2022) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2022.07.024 · Cited by 45 · see citing works
Treatment of primary sclerosing cholangitis in children
Laborda, T. J., Jensen, M. K., Kavan, M., & Deneau, M. R. (2019) · World Journal of Hepatology · doi:10.4254/wjh.v11.i1.19 · Cited by 42 · see citing works
Fossdal, G., Mjelle, A. B., Wiencke, K., Bjørk, I., Gilja, O. H., Folseraas, T., Karlsen, T. H., Rosenberg, W. M., Giil, L. M., & Vesterhus, M. N. (2021) · JHEP Reports · doi:10.1016/j.jhepr.2021.100328 · Cited by 39 · see citing works
Self-citationPrimary Sclerosing Cholangitis: A Concise Review of Diagnosis and Management
Fricker, Z. P., & Lichtenstein, D. R. (2019) · Digestive Diseases and Sciences · doi:10.1007/s10620-019-05484-y · Cited by 40 · see citing works
Nielsen, M. J., Thorburn, D., Leeming, D. J., Hov, J. R., Nygård, S., Moum, B. A., Saffioti, F., Gilja, O. H., Boberg, K. M., Mazza, G., et al. (2018) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14806 · Cited by 38 · see citing works
Self-citationEnhanced liver Fibrosis® test predicts liver-related outcomes in the general population
Saarinen, K., Färkkilä, M. A., Jula, A., Erlund, I., Vihervaara, T., Lundqvist, A., & Åberg, F. O. (2023) · JHEP Reports · doi:10.1016/j.jhepr.2023.100765 · Cited by 37 · see citing works
Self-citationSimbrunner, B., Marculescu, R., Scheiner, B., Schwabl, P., Bucsics, T., Stadlmann, A., Bauer, D. J. M., Paternostro, R., Eigenbauer, E., Pinter, M., et al. (2020) · Liver International · doi:10.1111/liv.14498 · Cited by 37 · see citing works
Jhaveri, K. S., Hosseini‐Nik, H., Sadoughi, N., Janssen, H. L. A., Feld, J. J., Fischer, S. E., Menezes, R. J., & Cheung, A. (2018) · European Radiology · doi:10.1007/s00330-018-5619-4 · Cited by 32 · see citing works
Bossen, L., Gerussi, A., Lygoura, V., Mells, G. F., Carbone, M., & Invernizzi, P. (2018) · Autoimmunity Reviews · doi:10.1016/j.autrev.2018.02.013 · Cited by 33 · see citing works
Selvaraj, E. A., Ba‐Ssalamah, A., Poetter‐Lang, S., Ridgway, G. R., Brady, J. M., Collier, J. D., Culver, E. L., Bailey, A. A., & Pavlides, M. (2021) · Hepatology Communications · doi:10.1002/hep4.1860 · Cited by 30 · see citing works
Systematic review: non‐invasive prognostic tests for primary sclerosing cholangitis
Mazhar, A., & Russo, M. W. (2021) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.16296 · Cited by 28 · see citing works
Trauner, M. A., Chung, C., Sterling, K., Liu, X., Lu, X., Xu, J., Tempany, C. M., Goodman, Z. D., Färkkilä, M. A., Tanaka, A., et al. (2023) · BMC Gastroenterology · doi:10.1186/s12876-023-02653-2 · Cited by 27 · see citing works
Self-citationModulation of hyaluronan signaling as a therapeutic target in human disease
Garantziotis, S. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107993 · Cited by 26 · see citing works
Braadland, P. R., Schneider, K. M., Bergquist, A. M., Molinaro, A., Lövgren‐Sandblom, A., Henricsson, M., Karlsen, T. H., Vesterhus, M. N., Trautwein, C., Hov, J. R., et al. (2022) · JHEP Reports · doi:10.1016/j.jhepr.2022.100561 · Cited by 26 · see citing works
Self-citationAdvances in the diagnosis and treatment of liver fibrosis
Cheng, J. Y., & Wong, G. L. (2017) · Hepatoma Research · doi:10.20517/2394-5079.2017.27 · Cited by 25 · see citing works
Serological biomarkers for management of primary sclerosing cholangitis
Tornai, D., Ven, P. L., Lakatos, P. L., & Papp, M. (2022) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i21.2291 · Cited by 24 · see citing works
Trivedi, P. J., Arndtz, K., Abbas, N., Telford, A., Young, L. A. J., Banerjee, R., Eddowes, P. J., Jhaveri, K. S., & Hirschfield, G. M. (2024) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.17944 · Cited by 24 · see citing works
Evolving role of magnetic resonance techniques in primary sclerosing cholangitis
Selvaraj, E. A., Culver, E. L., Bungay, H. K., Bailey, A. A., Chapman, R. W., & Pavlides, M. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i6.644 · Cited by 24 · see citing works
Vesterhus, M. N., Nielsen, M. J., Hov, J. R., Saffioti, F., Manon‐Jensen, T., Leeming, D. J., Moum, B. A., Boberg, K. M., Pinzani, M., Karlsen, T. H., et al. (2020) · JHEP Reports · doi:10.1016/j.jhepr.2020.100178 · Cited by 23 · see citing works
Self-citationSaffioti, F., & Mavroeidis, V. K. (2021) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v13.i10.1336 · Cited by 23 · see citing works
Self-citationBossen, L., Vesterhus, M. N., Hov, J. R., Färkkilä, M. A., Rosenberg, W. M., Møller, H. J., Boberg, K. M., Karlsen, T. H., & Grønbæk, H. (2021) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000000315 · Cited by 22 · see citing works
Self-citationFiorucci, S., Urbani, G., Giorgio, C. D., Biagioli, M., & Distrutti, E. (2024) · Cells · doi:10.3390/cells13191650 · Cited by 22 · see citing works
Utility of Noninvasive Markers of Fibrosis in Cholestatic Liver Diseases
Corpechot, C. (2016) · Clinics in Liver Disease · doi:10.1016/j.cld.2015.08.013 · Cited by 19 · see citing works
Nielsen, M. J., Dolman, G. E., Harris, R., Frederiksen, P., Chalmers, J., Grove, J. I., Irving, W. L., Karsdal, M. A., Patel, K., Leeming, D. J., et al. (2023) · JHEP Reports · doi:10.1016/j.jhepr.2023.100743 · Cited by 20 · see citing works
Mjelle, A. B., Mulabecirovic, A., Hausken, T., Havre, R. F., Gilja, O. H., & Vesterhus, M. N. (2016) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2016.04.016 · Cited by 18 · see citing works
Self-citationCurrent Therapeutics in Primary Sclerosing Cholangitis
Tan, N., Lubel, J. S., Kemp, W. W., Roberts, S. K., & Majeed, A. (2023) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2022.00068s · Cited by 17 · see citing works
Saffioti, F., Roccarina, D., Vesterhus, M. N., Hov, J. R., Rosenberg, W. M., Pinzani, M., Pereira, S. P., Boberg, K. M., & Thorburn, D. (2019) · European Journal of Clinical Investigation · doi:10.1111/eci.13088 · Cited by 16 · see citing works
Self-citationPrimary sclerosing cholangitis
von Seth, E., Karlsen, T. H., Tanaka, A., Ponsioen, C. Y., & Bergquist, A. M. (2026) · The Lancet · doi:10.1016/s0140-6736(25)02582-6 · Cited by 17 · see citing works
Self-citationSchmeltzer, P. A., & Russo, M. W. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10194476 · Cited by 15 · see citing works
Laursen, T. L., Bossen, L., Pihl, R., Troldborg, A., Sandahl, T. D., Hansen, A. G., Folseraas, T., Vesterhus, M. N., Grønbæk, H., & Thiel, S. (2022) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2021.00515 · Cited by 15 · see citing works
Self-citationGreenman, R., Snir, T., Katav, A., Aricha, R., Mishalian, I., Hay, O., Frankel, M. B., Lawler, J., Saffioti, F., Pinzani, M., et al. (2024) · Cells · doi:10.3390/cells13030209 · Cited by 15 · see citing works
Self-citationTrivedi, P. J. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.08.013 · Cited by 14 · see citing works
Medical treatment of primary sclerosing cholangitis: What have we learned and where are we going?
Karlsen, T. H., Jørgensen, K. K., & Bergquist, A. M. (2024) · Hepatology · doi:10.1097/hep.0000000000001172 · Cited by 14 · see citing works
Self-citationEndpoints in the design of clinical trials for primary sclerosing cholangitis
Ponsioen, C. Y. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.08.015 · Cited by 14 · see citing works
Self-citationSaffioti, F., Hall, A. R., de Krijger, M., Verheij, J., Hübscher, S. G., Maurice, J. B., Luong, T. V., Pinzani, M., Ponsioen, C. Y., & Thorburn, D. (2021) · Liver International · doi:10.1111/liv.14979 · Cited by 14 · see citing works
Self-citationDhillon, A. K., Rupp, C., Bergquist, A. M., Voitl, R., Folseraas, T., Trøseid, M., Midttun, Ø., Ueland, P. M., Karlsen, T. H., Vesterhus, M. N., et al. (2021) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2021.1880627 · Cited by 13 · see citing works
Self-citationCholangiocarcinoma: The era of liquid biopsy
Kotsifa, E., Saffioti, F., & Mavroeidis, V. K. (2025) · World Journal of Gastroenterology · doi:10.3748/wjg.v31.i11.104170 · Cited by 12 · see citing works
Self-citationHirschfield, G. M., Kowdley, K. V., Trivedi, P. J., Eksteen, B., Hameed, B., Vincent, C., Chen, T., Goel, A., Reddy, K. G., Orman, E. S., et al. (2025) · Journal of Hepatology · doi:10.1016/j.jhep.2025.09.016 · Cited by 12 · see citing works
Self-citationThe Swedish initiative for the study of Primary sclerosing cholangitis (SUPRIM)
Cornillet, M., Villard, C., Rorsman, F., Molinaro, A., Nilsson, E., Kechagias, S., von Seth, E., & Bergquist, A. M. (2024) · EClinicalMedicine · doi:10.1016/j.eclinm.2024.102526 · Cited by 12 · see citing works
Liver Elastography in Primary Sclerosing Cholangitis Patients Using Three Different Scanner Systems
Mjelle, A. B., Fossdal, G., Gilja, O. H., & Vesterhus, M. N. (2020) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2020.03.025 · Cited by 12 · see citing works
Self-citationNon-invasive diagnosis and follow-up of primary sclerosing cholangitis
Chazouillères, O., Potier, P., Bouzbib, C., Hanslik, B., Heurgué, A., Nguyen-Khac, É., Gournay, J., Tanné, F., Bureau, C., Bourlière, M., et al. (2021) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2021.101775 · Cited by 12 · see citing works
Patel, P. J., Connoley, D. J., Rhodes, F., Srivastava, A., & Rosenberg, W. M. (2019) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/0004563219879962 · Cited by 12 · see citing works
Self-citationSnir, T., Greenman, R., Aricha, R., Frankel, M. B., Lawler, J., Saffioti, F., Pinzani, M., Thorburn, D., Mor, A., & Vaknin, I. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25116042 · Cited by 11 · see citing works
Self-citationWang, J., Huang, R., Liu, J., Lai, R., Liu, Y., Zhu, C., Qiu, Y., He, Z., Yin, S., Chen, Y., et al. (2023) · Journal of Viral Hepatitis · doi:10.1111/jvh.13808 · Cited by 11 · see citing works
UEG Week 2019 Poster Presentations
Jaeger, M.-C., Guiraud, L., Rolland, C., Rolland, C., Belot, A., Sebbag, M., Bermúdez‐Humarán, L. G., Langella, P., Vergnolle, N., & Deraison, C. (2019) · United European Gastroenterology Journal · doi:10.1177/2050640619854671 · Cited by 11 · see citing works
Song, C., Lewis, S. C., Kamath, A., Hectors, S. J. C. G., Putra, J., Kihira, S., Bane, O., Ahmad, J., Babb, J. S., Thung, S. N., et al. (2019) · Abdominal Radiology · doi:10.1007/s00261-019-02366-9 · Cited by 10 · see citing works
Prognostic models and autoimmune liver diseases
D’Amato, D., & Carbone, M. (2023) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2023.101878 · Cited by 10 · see citing works
Controversies in the management of primary sclerosing cholangitis
Nayagam, J. S. (2016) · World Journal of Hepatology · doi:10.4254/wjh.v8.i5.265 · Cited by 9 · see citing works
Dellavance, A., Fernandes, F. F., Shimabokuro, N., Latini, F. R. M., Baldo, D. C., Barreto, J. A., Marvulle, V., Andrade, L. E. C., & Ferraz, M. L. G. (2016) · Clinica Chimica Acta · doi:10.1016/j.cca.2016.08.006 · Cited by 9 · see citing works
The role of imaging in determining prognosis for primary sclerosing cholangitis: A systematic review
Al‐Judaibi, B., Segal, D., Marotta, P., Mosli, M., Zou, G., & Feagan, B. (2019) · Saudi Journal of Gastroenterology · doi:10.4103/sjg.sjg_478_18 · Cited by 8 · see citing works
Nagelkerke, S. C. J., Draijer, L. G., Benninga, M. A., Koot, B. G. P., & Tabbers, M. M. (2020) · Clinical Nutrition · doi:10.1016/j.clnu.2020.05.039 · Cited by 8 · see citing works
Autotaxin activity predicts transplant-free survival in primary sclerosing cholangitis
Dhillon, A. K., Kremer, A. E., Kummen, M., Boberg, K. M., Elferink, R. P. J. O., Karlsen, T. H., Beuers, U. H., Vesterhus, M. N., & Hov, J. R. (2019) · Scientific Reports · doi:10.1038/s41598-019-44762-7 · Cited by 8 · see citing works
Self-citationRusso, M. W. (2023) · World Journal of Hepatology · doi:10.4254/wjh.v15.i9.1013 · Cited by 7 · see citing works
Nierath, W., Leitner, E., Reimann, S., Schwarz, R., Hinz, B., Bleich, A., Vollmar, B., & Zechner, D. (2024) · The FASEB Journal · doi:10.1096/fj.202400733r · Cited by 6 · see citing works
(2022) · British Journal of Gastroenterology · doi:10.31488/bjg.1000128 · Cited by 6 · see citing works
Deneau, M. R., Valentino, P. L., Mack, C. L., Alqoaer, K., Amin, M. D., Amir, A. Z., Aumar, M., Auth, M. K. H., Broderick, A., DiGuglielmo, M., et al. (2019) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000002522 · Cited by 5 · see citing works
Bowlus, C. L., Thorburn, D., Barclay, S. T., Joshi, D., Londoño, M., Mantry, P., Safadi, R., Aricha, R., Cirillo, C., Frankel, M. B., et al. (2025) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000003853 · Cited by 4 · see citing works
Self-citation
- Authors
- Vesterhus, M., Hov, J. R., Holm, A., Schrumpf, E., Nygård, S., Godang, K., Andersen, I. M., Næss, S., Thorburn, D., Saffioti, F., Vatn, M., Gilja, O. H., Lund‐Johansen, F., Syversveen, T., Brabrand, K., Parés, A., Ponsioen, C. Y., Pinzani, M., Färkkilä, M., Moum, B., Ueland, T., Røsjø, H., Rosenberg, W., Boberg, K. M., & Karlsen, T. H.
- Affiliations
- Oslo University Hospital (NO)
- Royal Free London NHS Foundation Trust (GB)
- Corresponding author
- Karlsen, Tom H.
- ORCID
- Vesterhus, Mette
- Hov, Johannes Roksund
- Nygård, Ståle
- Godang, Kristin
- Andersen, Ina Marie
- Thorburn, Douglas
- Saffioti, Francesca
- Gilja, Odd Helge
- Lund‐Johansen, Fridtjof
- Syversveen, Trygve
- Parés, Albert
- Ponsioen, Cyriel Y.
- Pinzani, Massimo
- Färkkilä, Martti
- Moum, Bjørn
- Ueland, Thor
- Røsjø, Helge
- Rosenberg, William
- Boberg, Kirsten Muri
- Karlsen, Tom H.
- Venue
- Hepatology
- Published
- 2015-04-28
- Volume
- 62
- Issue
- 1
- Pages
- 188-197
- ISSN
- 0270-9139 (ISSN-L)
- 1527-3350
- OpenAlex
- W1869119189
- Cited by
- 138
- References
- 41
- Citations by year
- 2026: 10 · 2025: 7 · 2024: 11 · 2023: 12 · 2022: 10 · 2021: 13 · 2020: 12 · 2019: 16 · 2018: 16 · 2017: 16 · 2016: 10 · 2015: 5
- FWCI
- 9.27
- Type
- journal article
- Language
- en
- Open access
- green
- pure.amsterdamumc.nl
- Licence
- Locations
- Hepatology (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (submittedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- National Institute for Health and Care Research (NF-SI-0512-10124)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Epidemiology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Surgery › Pediatric Hepatobiliary Diseases and Treatments
- Keywords
- primary sclerosing cholangitis, enhanced liver fibrosis test, transplant-free survival, prognostic factors, liver fibrosis, hyaluronic acid, TIMP-1, Mayo risk score, ultrasound elastography, disease activity, ulcerative colitis, liver transplantation, serum biomarkers
- MeSH terms
- Adult, Female, Fibrosis, Humans, Liver, Male, Middle Aged, Norway, Severity of Illness Index, Cholangitis, Sclerosing, Case-Control Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
